Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2009;104:1337-1346
Published online before print May 14, 2009, doi: 10.1161/CIRCRESAHA.108.187088
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
104/12/1337    most recent
CIRCRESAHA.108.187088v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Fu, Z.
Right arrow Articles by Van Eyk, J. E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fu, Z.
Right arrow Articles by Van Eyk, J. E.
Related Collections
Right arrow Pathophysiology
Right arrow Smooth muscle proliferation and differentiation
Right arrow Mechanism of atherosclerosis/growth factors
Right arrow Other Vascular biology
(Circulation Research. 2009;104:1337.)
© 2009 American Heart Association, Inc.


Molecular Medicine

Milk Fat Globule Protein Epidermal Growth Factor-8

A Pivotal Relay Element Within the Angiotensin II and Monocyte Chemoattractant Protein-1 Signaling Cascade Mediating Vascular Smooth Muscle Cells Invasion

Zongming Fu*, Mingyi Wang*, Marjan Gucek, Jing Zhang, James Wu, Liqun Jiang, Robert E. Monticone, Benjamin Khazan, Richard Telljohann, Julie Mattison, Simon Sheng, Robert N. Cole, Gaia Spinetti, Gianfranco Pintus, Lijuan Liu, Frank D. Kolodgie, Renu Virmani, Harold Spurgeon, Donald K. Ingram, Allen D. Everett, Edward G. Lakatta*, Jennifer E. Van Eyk*

From the Department of Medicine (Z.F., S.S., J.E.V.E.); Technical Implementation and Coordination Core (M.G., R.N.C., J.E.V.E.), The Johns Hopkins Bayview Proteomics Center; Department of Neurology (L.L.); Department of Pediatrics (A.D.E.); Department of Biomedical Engineering (J.E.V.E.); and Department of Biological Chemistry (J.E.V.E.), The Johns Hopkins University, Baltimore, Md; Laboratory of Cardiovascular Science (M.W., L.J., R.E.M., B.K., R.T., H.S., E.G.L.) and Laboratory of Experimental Gerontology (J.M.), National Institute on Aging, NIH, Baltimore, Md; Medstar Research Institute (J.Z., J.W.), Hyattsville, Md; IRCCS MultiMedica (G.S.), Milano, Italy; Department of Biomedical Sciences (G.P.), University of Sassari, Italy; CVPath (F.D.K., R.V.), International Registry of Pathology, Gaithersburg, Md; and Nutritional Neuroscience and Aging Laboratory (D.K.I.), Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge.

Correspondence to Mingyi Wang, MD, PhD, Laboratory of Cardiovascular Science, National Institute on Aging-National Institutes of Health, Baltimore, MD 21224. E-mail: mingyiw{at}grc.nia.nih.gov

Advancing age induces aortic wall thickening that results from the concerted effects of numerous signaling proteins, many of which have yet to be identified. To search for novel proteins associated with aortic wall thickening, we have performed a comprehensive quantitative proteomic study to analyze aortic proteins from young (8 months) and old (30 months) rats and identified 50 proteins that significantly change in abundance with aging. One novel protein, the milk fat globule protein epidermal growth factor 8 (MFG-E8), increases 2.3-fold in abundance in old aorta. Transcription and translation analysis demonstrated that aortic MFG-E8 mRNA and protein levels increase with aging in several mammalian species including humans. Dual immunolabeling shows that MFG-E8 colocalizes with both angiotensin II and monocyte chemoattractant protein (MCP)-1 within vascular smooth muscle cells (VSMCs) of the thickened aged aortic wall. Exposure of early passage VSMCs from young aorta to angiotensin II markedly increases MFG-E8 and enhances invasive capacity to levels observed in VSMCs from old rats. Treatment of VSMCs with MFG-E8 increases MCP-1 expression and VSMCs invasion that are inhibited by the MCP-1 receptor blocker vCCI. Silencing MFG-E8 RNA substantially reduces MFG-E8 expression and VSMCs invasion capacity. The data indicate that arterial MFG-E8 significantly increases with aging and is a pivotal relay element within the angiotensin II/MCP-1/VSMC invasion signaling cascade. Thus, targeting of MFG-E8 within this signaling axis pathway is a potential novel therapy for the prevention and treatment of the age-associated vascular diseases such as atherosclerosis.


Key Words: MFG-E8 • angiotensin II • monocyte chemoattractant protein-1 • vascular smooth muscle cells • aging